Remgro Valuation Multiples

Remgro is valued at $7.1B as of October 2026, a 2.0x revenue multiple. In the last fiscal year, Remgro revenue was $3.2B and Remgro EBITDA was $396M.

Remgro Overview

About Remgro

Remgro Ltd is an investment holding company with investments in the healthcare, consumer products, financial services, infrastructure, industrial, and media industries. Its segments include Consumer Products and Industrial and Other. It derives the majority of its revenue from Consumer Products.


Founded

1940

HQ

South Africa

Employees

175

Website

remgro.com

Financials (Last FY)

Revenue: $3.2B
EBITDA: $396M

EV

$6.3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Remgro Financials

Remgro reported last fiscal year revenue of $3.2B and EBITDA of $396M.

In the same fiscal year, Remgro generated $1B in gross profit, $396M in EBITDA, and $88M in net income.

Revenue (LTM)


Remgro P&L

In the most recent fiscal year, Remgro reported revenue of $3.2B and EBITDA of $396M.

Remgro is profitable as of last fiscal year, with gross margin of 32%, EBITDA margin of 12%, and net margin of 3%.

See analyst estimates for Remgro
LTMLast FY202320242025202620272028
Revenue-$3.2B$3.2B$3.3B$3.1B
Gross Profit-$1B$964M$949M$1.1B
Gross Margin-32%30%29%36%
EBITDA-$396M$219M$185M$330M
EBITDA Margin-12%7%6%11%
EBIT Margin-11%9%9%9%
Net Profit$702M$88M$337M$141M$271M
Net Margin-3%11%4%9%
Net Debt-($653M)---

Financial data powered by Morningstar, Inc.

Remgro Stock Performance

Remgro has current market cap of $7.1B, and enterprise value of $6.3B.

Market Cap Evolution


Remgro's stock price is $12.81.

Remgro share price increased by 4.1% in the last 30 days, and by 28.8% in the last year.

Remgro has an EPS (earnings per share) of $0.16.

See more trading valuation data for Remgro
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6.3B$7.1B1.9%4.1%8.1%28.8%$0.16

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Remgro Valuation Multiples

Remgro trades at 2.0x EV/Revenue multiple, and 15.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Remgro

EV / Revenue (LTM)


Remgro Financial Valuation Multiples

As of October 22, 2026, Remgro has market cap of $7.1B and EV of $6.3B.

Remgro has a P/E ratio of 10.2x.

LTMLast FY202320242025202620272028
EV/Revenue-2.0x2.0x1.9x2.0x
EV/EBITDA-15.9x28.7x34.0x19.1x
EV/EBIT-18.3x21.4x21.9x23.7x
EV/Gross Profit-6.1x6.5x6.6x5.6x
P/E10.2x81.3x21.2x50.6x26.3x
EV/FCF-13.5x99.5x26.3x16.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Remgro Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Remgro Margins & Growth Rates

In the most recent fiscal year, Remgro reported gross margin of 32%, EBITDA margin of 12%, and net margin of 3%.

See estimated margins and future growth rates for Remgro

Remgro Margins

Last FY20242025202720282029
Gross Margin32%29%36%
EBITDA Margin12%6%11%
EBIT Margin11%9%9%
Net Margin3%4%9%
FCF Margin14%7%12%

Remgro Growth Rates

23/2424/2525/2626/2727/2828/29
Revenue Growth2%(5%)-
Gross Profit Growth(2%)18%-
EBITDA Growth(16%)78%-
EBIT Growth(2%)(8%)-
Net Profit Growth(58%)92%52%
FCF Growth278%56%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Remgro Operational KPIs

Remgro's revenue per employee in the last FY averaged $18.4M, while opex per employee averaged $3.9M for the same period.

Access forward-looking KPIs for Remgro
Last FY202320242025202620272028
Revenue per Employee$18.4M---
Opex per Employee$3.9M---
Opex to Revenue21%21%20%21%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
China Industrial Securities$1.8B-4.0x3.5x--
Sprott Physical Gold$4.4B-1.6x---
Jardine Cycle & Carriage$21B$4.4B1.0x1.1x4.8x6.2x
St James's Place$40B$1.8B----
Infratil$1.7B$676M7.0x5.7x17.6x19.3x
Migdal Group$11B$1.1B----
Intermediate Capital Group$1.4B$801M10.0x10.6x17.8x18.1x
TPG$4.8B$1.1B2.5x4.7x10.5x9.2x

This data is available for Pro users. Sign up to see all Remgro competitors and their valuation data.

Start Free Trial

Acquisitions by Remgro

Remgro has acquired 2 companies to date.

Last acquisition by Remgro was on March 30th 2026. Remgro acquired Mediclinic Southern Africa for $950M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Remgro

Mediclinic Southern Africa
Mediclinic International
Description
Mediclinic Southern Africa operates private hospitals for multi-disciplinary acute care.
Mediclinic is an international private hospital group headquartered in Stellenbosch, South Africa, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates. It runs acute-care hospitals, day-case clinics and outpatient facilities, including the Hirslanden group in Switzerland and Mediclinic Middle East, and holds a 29.9% interest in the UK private healthcare group Spire Healthcare. The group earns revenue from inpatient and outpatient services paid by medical schemes, insurers and patients, and reported revenue of ÂŁ3,233 million in 2022, with more than 37,000 employees across 134 facilities in 2024. Mediclinic was founded in 1983 in Stellenbosch by Dr Edwin Hertzog, commissioned by the Rembrandt Group, now Remgro, and listed on the JSE in 1986. It bought Hirslanden in 2007 and, after a reverse merger with Al Noor Hospitals, began trading on the London Stock Exchange in February 2016. A consortium of Remgro and MSC Mediterranean Shipping Company took it private in 2023 after a ÂŁ3.7 billion offer announced in August 2022, and in April 2026 Remgro agreed to take full ownership of Mediclinic Southern Africa while Hirslanden is sold to IHL.
HQ CountrySouth AfricaSouth Africa
HQ City
Vereeniging
Stellenbosch
Deal Date30 Mar 20264 Aug 2022
Valuation$950M$7.7B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Remgro acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Remgro

When was Remgro founded?Remgro was founded in 1940.
Where is Remgro headquartered?Remgro is headquartered in South Africa.
How many employees does Remgro have?As of today, Remgro has over 175 employees.
Who is the CEO of Remgro?Remgro's CEO is Jannie Durand.
Is Remgro publicly listed?Yes, Remgro is a public company listed on Johannesburg Stock Exchange.
What is the stock symbol of Remgro?Remgro trades under REM ticker.
When did Remgro go public?Remgro went public in 2000.
Who are competitors of Remgro?Remgro main competitors include China Industrial Securities, Sprott Physical Gold, Jardine Cycle & Carriage, St James's Place, Infratil, Migdal Group, Intermediate Capital Group, TPG, FUNO, VZ VermögensZentrum.
What is the current market cap of Remgro?Remgro's current market cap is $7.1B.
What is the current revenue of Remgro?Remgro's last fiscal year revenue is $3.2B.
What is the current EV/Revenue multiple of Remgro?Current revenue multiple of Remgro is 2.0x.
What is the current net income of Remgro?Remgro's last 12 months net income is $702M.
How many companies Remgro has acquired to date?As of October 2026, Remgro has acquired 2 companies.
What was the largest acquisition by Remgro?$7.7B acquisition of Mediclinic International on 4th August 2022 was the largest M&A Remgro has done to date.
What companies Remgro acquired?Remgro acquired Mediclinic International and Mediclinic Southern Africa.
In how many companies Remgro has invested to date?Remgro hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Remgro

Lists including Remgro

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial